Crinetics Pharmaceuticals, Inc. Unrecognized Tax Benefits
Crinetics Pharmaceuticals, Inc. (CRNX) had Unrecognized Tax Benefits of $14.75 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefits · last filed 2026-02-26
- 2025-12-31: Unrecognized Tax Benefits $14.75M.
- 2024-12-31: Unrecognized Tax Benefits $10.69M.
- 2023-12-31: Unrecognized Tax Benefits $6.95M.
- 2022-12-31: Unrecognized Tax Benefits $4.11M.
| Period end | Unrecognized Tax Benefits |
|---|---|
| 2025-12-31 | $14.75M 10-K · filed 2026-02-26 |
| 2024-12-31 | $10.69M 10-K · filed 2026-02-26 |
| 2023-12-31 | $6.95M 10-K · filed 2026-02-26 |
| 2022-12-31 | $4.11M 10-K · filed 2026-02-26 |
| 2021-12-31 | $1.55M 10-K · filed 2025-02-27 |
| 2020-12-31 | $1.09M 10-K · filed 2024-02-28 |
| 2019-12-31 | $886.00K 10-K · filed 2023-02-28 |
| 2018-12-31 | $344.00K 10-K · filed 2022-03-30 |
| 2017-12-31 | $159.00K 10-K · filed 2021-03-30 |
| 2016-12-31 | $68.00K 10-K · filed 2020-03-09 |
| 2015-12-31 | $0.00 10-K · filed 2019-03-13 |